Nuvectis Pharma Inc
(NVCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCT | PLX | OBIO | ||
| Company | Nuvectis Pharma Inc | Protalix Biotherapeutics | Orchestra Biomed Hldgs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 8.84 | 2.93 | 4.11 | ||
| High | 9.03 | 2.95 | 4.22 | ||
| Low | 8.51 | 2.85 | 3.78 | ||
| Latest | 8.80 | 2.86 | 3.82 | ||
| Change | +0.02 | -0.06 | -0.24 | ||
| % Change | +0.23% | -2.05% | -5.91% | ||
| Volume | 78,000 | 862,300 | 130,400 | ||
| 20-Day Average Volume | 63,515 | 1,512,860 | 201,820 | ||
| Previous Close | 8.78 | 2.92 | 4.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.56 | 2.42 | 3.97 | ||
| 20-Day Raw Stochastic | 67.42% | 84.36% | 33.64% | ||
| 20-Day Relative Strength | 57.39 | 69.58 | 45.54 | ||
| Weighted Alpha | +18.61 | +62.57 | +4.60 | ||
| Today's Opinion | 88% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 72% Buy | 24% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.64% since 02/05/26 | -1.72% since 02/05/26 | +2.96% since 02/05/26 | ||
| Low | 8.12 on 02/11/26 | 2.64 on 02/10/26 | 3.62 on 02/06/26 | ||
| High | 9.22 on 02/09/26 | 2.95 on 02/12/26 | 4.24 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +7.32% since 01/12/26 | +36.19% since 01/12/26 | -18.03% since 01/12/26 | ||
| Low | 7.94 on 01/30/26 | 1.97 on 01/21/26 | 3.46 on 01/30/26 | ||
| High | 9.22 on 02/09/26 | 3.03 on 02/05/26 | 4.70 on 01/13/26 | ||
| 3-Month | |||||
| %Chg | +46.42% since 11/12/25 | +33.64% since 11/12/25 | -13.57% since 11/12/25 | ||
| Low | 5.77 on 12/02/25 | 1.65 on 12/03/25 | 3.46 on 01/30/26 | ||
| High | 9.44 on 01/08/26 | 3.03 on 02/05/26 | 5.42 on 11/26/25 | ||
| 6-Month | |||||
| %Chg | +29.03% since 08/12/25 | +74.39% since 08/12/25 | +40.44% since 08/12/25 | ||
| Low | 5.55 on 11/07/25 | 1.46 on 08/15/25 | 2.20 on 09/24/25 | ||
| High | 9.44 on 01/08/26 | 3.03 on 02/05/26 | 5.42 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 225,412 | 230,004 | 215,696 | ||
| Shares Outstanding, K | 25,615 | 80,421 | 56,465 | ||
| Annual Sales | 0 | 53,400,000 | 2,640,000 | ||
| Annual Net Income | -19,000,000 | 2,930,000 | -61,020,000 | ||
| Last Quarter Sales | 0 | 17,850,000 | 860,000 | ||
| Last Quarter Net Income | -7,460,000 | 2,360,000 | -20,830,000 | ||
| 60-Month Beta | -0.29 | -0.21 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 11/04/25 | 0.03 on 11/13/25 | -0.40 on 11/10/25 | ||
| Latest Earnings Date | 05/05/26 | 03/16/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.71 | 0.00 | ||